2C-EF

2C-EF
Clinical data
Other names	4-(2-Fluoroethyl)-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-(2-fluoroethyl)phenethylamine
Routes of; administration	Oral
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None;
Pharmacokinetic data
Metabolism	Deamination (MAOTooltip monoamine oxidase), demethylation, hydroxylation, acetylation, glucuronidation
Duration of action	12 hours
Identifiers
	IUPAC name 2-[4-(2-fluoroethyl)-2,5-dimethoxyphenyl]ethan-1-amine;
CAS Number	1222814-77-8;
PubChem CID	44350106;
ChemSpider	23206505;
ChEMBL	ChEMBL421439;
CompTox Dashboard (EPA)	DTXSID201336575 ;
Chemical and physical data
Formula	C12H18FNO2
Molar mass	227.279 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC(=C(C=C1CCN)OC)CCF;
	InChI InChI=1S/C12H18FNO2/c1-15-11-8-10(4-6-14)12(16-2)7-9(11)3-5-13/h7-8H,3-6,14H2,1-2H3; Key:KXPMRPNOYIOXFY-UHFFFAOYSA-N;

2C-EF, also known as 4-(2-fluoroethyl)-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is the 2C analogue of the DOx psychedelic DOEF. The drug is taken orally. 2C-EF was first described in the literature by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved.